VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 1508471
Sex: F
Age:
State: VT

Vax Date: 04/24/2021
Onset Date: 04/28/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Extreme dizziness; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the arm left on 24Apr2021 at 18:30 as a single dose(at the age of 24-years-old) for COVID-19 immunisation. Concomitant medications included cholecalciferol (VITAMIN D3) from unknown date for unknown indication, magnesium supplement (MANUFACURER UNKNOWN) from unknown date for unknown indication and multivitamin (MANUFACURER UNKNOWN) from unknown date for unknown indication. The patient previously took cefdinir. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 06:00, the patient experienced extreme dizziness. Therapeutic measures taken were not reported. The clinical outcome of the event extreme dizziness was not resolved at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN D3; MAGNESIUM

Current Illness:

ID: 1508472
Sex: F
Age:
State: PA

Vax Date: 03/11/2021
Onset Date: 03/12/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: vaginal cramping; spotting; This is a spontaneous report from a non-contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the right arm on 11Mar2021 at 10:30 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension from an unspecified date. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Mar2021 at 06:30 the patient experienced vaginal cramping and spotting the morning after the vaccination was received. The clinical outcome of the event spotting vaginal, cramp was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508473
Sex: M
Age:
State: MA

Vax Date: 04/04/2021
Onset Date: 04/09/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Carpal Tunnel both hands; pain; numbness; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 04Apr2021 at 13:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included metformin (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 the patient experienced Carpal Tunnel both hands, pain, numbness. The patient received treatment for the events. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event carpal tunnel syndrome, pain, numbness was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: METFORMIN

Current Illness:

ID: 1508474
Sex: F
Age:
State: OH

Vax Date: 04/07/2021
Onset Date: 04/11/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I had a drink of coffee and asked my husband if he brunt it because it tasted odd, then since then my taste on several food and drink items has changed. It's a gross taste in my mouth upon smell the item and even while eating.; I can't really smell bleach, my toothpaste (2 different brands) and other food all taste/smell the same.; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ew0150), via an unspecified route of administration in the left arm on 07Apr2021 at 18:30 (at the age of 38-years-old) as single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medication taken within two weeks included ethinylestradiol; norgestimate (SPRINTEC) from an unknown date for birth control. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. On 11Apr2021 at 08:00, the patient experienced taste change and smell loss. The patient had a drink of coffee and asked her husband if he had brunt it because it tasted odd, then since then her taste on several food and drink items had changed. It was gross taste in her mouth upon smell the item and even while eating. There were several things the patient just couldn't eat because it was gross but she used to highly enjoy them. The patient couldn't really smell bleach, her toothpaste (2 different brands) and other food all tasted/smelled the same. The clinical outcome of the event taste change and smell change was not resolved at the time of this report. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ew0179), via an unspecified route of administration in the left arm on 28Apr2021 at 18:30 (at the age of 38-years-old) as single dose for COVID-19 immunisation and the adverse events for the second dose were not reported. No follow-up attempts are needed. No further information is expected.

Other Meds: SPRINTEC

Current Illness:

ID: 1508475
Sex: F
Age:
State: MI

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Body aches; heart palpitations; Low grade fever; five days post shot extreme fatigue/exhaustion to point I could not get out of bed; First and second day post shot a little tired;; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the arm right on 15Apr2021 at 11:15(at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included hashimoto's disease and reaction to preservatives(Preservatives in shots). Concomitant medications included levothyroxine sodium (SYNTHROID), cetirizine hydrochloride (ZYRTEC),famotidine (MANUFACTURER UNKNOWN) and Estrogen patch(Manufacturer unknown) from unknown dates for unknown indication. The patient previously received Biaxin, Sulfur and penicillin. The patient previously received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:ER2613 ) via an unspecified route of administration in the arm right on 22Mar2021 at 13:15(at the age of 62-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 15Apr2021 the patient experienced little tired First and second day post shot. On 20Apr2021 at 08:00 five days post shot extreme fatigue/exhaustion to point she could not get out of bed, heart palpitations, low grade fever, body aches. The clinical outcome of the event First and second day post shot a little tired; was recovered. The clinical outcome of the event Body aches was recovered. The clinical outcome of the event heart palpitations was recovered. The clinical outcome of the event Low grade fever was recovered. The clinical outcome of the event five days post shot fatigue/exhaustion was recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: SYNTHROID; Zyrtec; FAMOTIDINE

Current Illness:

ID: 1508476
Sex: M
Age:
State: NY

Vax Date: 04/27/2021
Onset Date: 04/28/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; low fever; nausea; fatigue; loss of appetite; general discomfort; sore arm; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the arm right on 27Apr2021 at 10:30(at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included food allergy like allergy to walnuts, apples and many stone fruits. Concomitant medications included cetirizine hydrochloride (ZYRTEC) and naproxen sodium (ALEVE) since an unknown date for an unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the arm right on 06Apr2021 at 14:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 28Apr2021 at 02:00, the patient experienced headache, low fever, nausea, fatigue, loss of appetite, general discomfort and sore arm. It began approximately 14 hours after injection and easing 28 hours after injection and completely gone within 40 hours but still had sore arm. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event headache, low fever, nausea, fatigue, loss of appetite and general discomfort were recovered on an unknown date in Apr2021. The clinical outcome of the event sore arm was not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds: Zyrtec; ALEVE

Current Illness:

ID: 1508477
Sex: M
Age:
State: PA

Vax Date: 04/18/2021
Onset Date: 04/20/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen lymph nodes in neck, head, collar bone, shoulder and chest; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 18Apr2021 at 10:00(at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies from an unknown date. Concomitant medication included rosuvastatin (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 20Apr2021 at 17:00, the patient experienced swollen lymph nodes in neck, head, collar bone, shoulder and chest. Swollen lymph nodes in collar bone and shoulder persisted 11 days later. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event swollen lymph nodes in neck, head, collar bone, shoulder and chest were not resolved at the time of this report. No follow-up attempts are needed; information about lot number cannot be obtained.

Other Meds: ROSUVASTATIN

Current Illness:

ID: 1508478
Sex: F
Age:
State: CO

Vax Date: 04/24/2021
Onset Date: 04/25/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: High fever; Severe headache; Bad vision.; Body aches.; No energy; Nausea; slept 20 hours; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: Er8763) via an unspecified route of administration in the left arm on 24Apr2021 at 12:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received penicillin for an unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Ew0150), via an unspecified route of administration in the left arm on 01Apr2021 at 13:00 (at the age of 55-years old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 25Apr2021 at 00:00, the patient had experienced high fever, severe headache, bad vision, body aches, nausea. She had slept for 20 hours and did not have energy. Five days later she was still sick. The clinical outcome of the events high fever, severe headache, bad vision, general body pains, no energy, nausea and slept 20 hours was resolving at the time of report. No follow-up attempts are needed. No further information is expected

Other Meds:

Current Illness:

ID: 1508479
Sex: F
Age:
State: GA

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swollen lymph node (left side); swollen lymph node (left side), tender to touch, painful at this point; leg hurting; lymph node (left side), tender to touch,; very lethargic, unable to keep energy; extremely tired; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 14Apr2021 at 10:30 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient previously took penicillin for an unknown indication on an unknown date and experienced allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 24Mar2021 at 12:00 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021, the patient underwent nasal swab test and the result was negative. On 14Apr2021, the patient experienced lethargic and tiredness. On 19Apr2021, the patient experienced swollen lymph nodes, lymph node tenderness, lymph node pain and leg pain. Its reported that the patient was feeling unwell since she received the shot, very lethargic, unable to keep energy up during the day, extremely tired, recently a swollen lymph node (left side), tender to touch, painful at this point, as well as leg hurting for a full day. Pain medication doesn't work well either. Therapeutic measures taken for the reported events included treatment with pain medications. The clinical outcome of the events of lethargic, tiredness, swollen lymph nodes, lymph node tenderness, and lymph node pain was not recovered at the time of this report. The clinical outcome of the event of lymph node pain was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: SPIRONOLACTONE

Current Illness:

ID: 1508480
Sex: M
Age:
State: WA

Vax Date: 04/02/2021
Onset Date: 04/23/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swollen lymph node on left jaw; itchy skin; This is a spontaneous report from a contactable other healthcare professional, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8737) via an unspecified route of administration in the arm left on 02Apr2021 at 16:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included finasteride (MANUFACTURER UNKNOWN) and minoxidil (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6199) via an unspecified route of administration in the arm left on 12Mar2021 at 16:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 16:00 the patient experienced swollen lymph node on left jaw and itchy skin. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events swollen lymph node on left jaw and itchy skin was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: FINASTERIDE; MINOXIDIL

Current Illness:

ID: 1508481
Sex: F
Age:
State: WA

Vax Date: 04/25/2021
Onset Date: 04/29/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 1 x 1.5 inch rash right under the injection site; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the arm right on 25Apr2021 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included norgestimate, ethinyl estradiol (Ortho tri-cyclen). Relevant past drug history was provided as not that the patient knows of. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 the patient experienced 1 x 1.5-inch rash right under the injection site (vaccination site rash). The clinical outcome of the event vaccination site rash was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ORTHO TRI-CYCLEN

Current Illness:

ID: 1508482
Sex: F
Age:
State: PA

Vax Date: 04/23/2021
Onset Date: 04/23/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: delayed menstrual cycle; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP8736) via an unspecified route of administration in the left arm on 23Apr2021 (at the age of 25- years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications included escitalopram oxalate (LEXAPRO) for unknown indication form unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0150) via an unspecified route of administration in the left arm on 02Apr2021.Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021, the patient underwent rapid COVID-19 virus test and the result was found to be negative. On 23Apr2021 the patient experienced delayed menstrual cycle. The clinical outcome of the event delayed menstrual cycle was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEXAPRO

Current Illness:

ID: 1508483
Sex: M
Age:
State: ME

Vax Date: 04/13/2021
Onset Date: 04/26/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I started having CCU - Cold Contact Urticaria on 4/26 or at least thats when I was exposed to cold and noticed hives; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the arm left on 13Apr2021 at 00:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was reported as none. Concomitant medication included liprosine (MANUFACTURER UNKNOWN). The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm left on 23Mar2021 at 00:00 (at the age of 62-years-old) for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021 at 00:00, the patient experienced CCU - Cold Contact Urticaria on 4/26 or at least that's when he was exposed to cold and noticed hives. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether the patient had received any treatment for the event. The clinical outcome of the event urticaria was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508484
Sex: F
Age:
State: WA

Vax Date: 04/22/2021
Onset Date: 04/22/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hives on face and neck; Hot ears; tingling/vibrating skin on face after any exercise daily (still occurring 7 days after shot); severe headaches; chills; fatigue; hot flashes; sleeplessness; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 22Apr2021 at 09:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient's had allergies to penicillin, pollen and tree nuts. The patient's concomitant medications included cetirizine hydrochloride(ZYRTEC, birth control medication (unspecified) and multivitamin. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 01Apr2021 at 12:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021 at 12:00, the patient experienced hives on face and neck, hot ears (red ears), tingling/vibrating skin on face after any exercise daily, severe headaches, chills, hot flashes, fatigue and sleeplessness. Therapeutic measures taken were not reported. The clinical outcome of the events hives, red ear syndrome, tingling skin, headaches, chills, hot flashes, fatigue and sleeplessness were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Zyrtec

Current Illness:

ID: 1508485
Sex: F
Age:
State: UT

Vax Date: 04/20/2021
Onset Date: 04/20/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: vision issues and seeing spots or wavy lines.; vision issues blurred; intense intermittent headaches; intense waves of nausea; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the arm left on 20Apr2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included mast cell activation syndrome, postural orthostatic tachycardia syndrome, hemiplegic migraine, hypertension, ehlers-danlos syndrome, and methylenetetrahydrofolate reductase deficiency. The patient received several unspecified medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 18Mar2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 20Apr2021 at 17:45, the patient experienced intense intermittent headaches, intense waves of nausea, vision issues blurred, and seeing spots or wavy lines. The patient was 9 days post 2nd dose at the time of reporting and was still experiencing the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event intense intermittent headaches, intense waves of nausea, vision issues blurred, and seeing spots or wavy lines were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected

Other Meds:

Current Illness:

ID: 1508486
Sex: M
Age:
State: CA

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fast heart beat; difficulty in breathing; dizziness; confusion; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 05Apr2021 at 10:30 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 12:00 the patient had experienced fast heartbeat, difficulty in breathing, dizziness and confusion after one hour of vaccine administration which was lasted for about 3 minutes or less. The reaction repeated again after 30 hours and lasted for about 2 minutes. But he reported only the effect that happened after 30 hours and not the initial experience. The clinical outcome of the events fast heartbeat, difficulty in breathing, dizziness and confusion was resolved on an unspecified date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508487
Sex: F
Age:
State: MI

Vax Date: 04/08/2021
Onset Date: 04/23/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Got really sick for a day about 2 weeks; Fever; Chills; Joint pains in hands, knees, hips, back and heels; Headache; Extreme fatigue; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 08Apr2021 at 11:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included attention deficit hyperactivity disorder and inflammatory arthritis. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included methylphenidate (MANUFACTURER UNKNOWN), multivitamins (MANUFACTURER UNKNOWN) and hydroxychloroquine (MANUFACTURER UNKNOWN) all for unknown indications from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 21:00 the patient got really sick (for a day), fever, chills, joint pains in hands, knees, hips, back and heels, headache, extreme fatigue and nausea. The events resulted in doctor or other healthcare professional office/clinic visit. On 25Apr2021, the patient underwent Sars-cov-2 RNA, QL, RT PCR (nasal swab) and the result was negative. The clinical outcome of the events got really sick was resolved on 24Apr2021; while that of fever, chills, joint pains in hands, knees, hips, back and heels, headache, extreme fatigue and nausea was resolved on an unknown date in Apr2021. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds: METHYLPHENIDATE; HYDROXYCHLOROQUINE

Current Illness:

ID: 1508488
Sex: M
Age:
State: KY

Vax Date: 04/22/2021
Onset Date: 04/29/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain; Rash; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 22Apr2021 at 14:15 (at the age of 56-years-old) as a single dose for COVID-19 immunization. Medical history included diabetes and heart disease, unspecified. The patient had allergies to walnuts and pecans. The patient previously took bactrim, trulicity and invokana and was allergic. Concomitant medications included metformin (MANUFACTURER UNKNOWN), apixaban (ELIQUIS), furosemide (LASIX), carvedilol (CARVIDOL) and insulin human injection, isophane (INSULIN N) from unknown dates for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 14:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 06:00, the patient experienced pain and rash. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures taken was not reported. The clinical outcome of the events pain and rash was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: INSULIN N; METFORMIN; ELIQUIS; Lasix; CARVIDOL

Current Illness:

ID: 1508489
Sex: F
Age:
State: PA

Vax Date: 04/27/2021
Onset Date: 04/27/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore left arm; Leg muscle pain; Fatigue; Low grade fever; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 27Apr2021 at 10:00 (at the age of 41-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications included norethisterone acetate; ethinylestradiol (JUNEL FE 24), levothyroxine 112 micrograms (MANUFACTURER UNKNOWN) and metformin hydrochloride (METFORMIN ER 500) all for an unknown indication from an unknown date. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 06Apr2021 at 10:00 (at the age of 41-year-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Apr2021 at 20:00, the patient experienced sore left arm for 48 hours, leg muscle pain for 08 hours, fatigue for 24 hours and low-grade fever for 30 hours. The clinical outcome of the events muscle pain was resolved on 28Apr2021 at 04:00; fatigue was resolved on 28Apr2021 at 20:00; low grade fever was resolved on 29Apr2021 at 02:00 and sore left arm was resolved on 29Apr2021 at 20:00. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: JUNEL FE 24; LEVOTHYROXINE; METFORMIN ER

Current Illness:

ID: 1508490
Sex: F
Age:
State: MI

Vax Date: 04/27/2021
Onset Date: 04/27/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swelling in the armpit and breast on the same side as the injection; Pain in the breast on the same side as the injection; Pain in the armpit on the same side as the injection; Body aches; Low grade fever; Fatigue; Light, red and non raised rash at the injection site; Non raised rash at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 27Apr2021 at 13:45 (at the age of 22-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and food allergy. Concomitant medications were not reported. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 06Apr2021 at 14:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Apr2021 at 15:30, the patient experienced pain and swelling in the armpit and breast on the same side as the injection, body aches, low grade fever, fatigue, light red non raised rash at the injection site. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events which included treatment with BENADRYL. The clinical outcome of the event swelling in the armpit and breast on the same side as the injection, pain in the armpit and breast on the same side as the injection, body aches, low grade fever, fatigue and light red non raised rash at the injection site were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508491
Sex: M
Age:
State: NY

Vax Date: 04/28/2021
Onset Date:
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Cold sweats; Body aches; Dehydrated; Sore arm; Headache; This is a spontaneous report from a contactable pharmacist. A 26-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications were not reported. Previously, the patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route on an unspecified date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date, the patient woke up in middle of the night after receiving vaccine the previous day (as reported) with cold sweats, body aches, headache all morning, sore arm and dehydrated. The adverse events were starting to subside then. The clinical outcome of the event cold sweats, body aches, headache, sore arm and dehydrated was recovering at the time of this report. No follow-up attempts are needed; information about lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1508492
Sex: F
Age:
State: IL

Vax Date: 04/14/2021
Onset Date: 04/23/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Back to back periods; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161), via an unspecified route of administration in the left arm on 14Apr2021 at 15:30(at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension (HTN), Crohn's disease and ulcerative colitis. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vedolizumab (ENTYVIO), mesalazine (MESALAMINE), amlodipine (AMLODIPINE) and olmesartan (OLMESARTAN) all taken from unknown dates for unknown indications. The patient previously received REMICADE for an unknown indication. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. The patient reported that on 16Apr2021, two days after the vaccination she had her period which lasted for four days and it was a normal cycle, then again on 23Apr2021, the patient experienced another period which lasted for four days and it was a normal cycle (irregular periods). The patient reported that the back-to-back periods were completely out of normal. The clinical outcome of the event back-to-back periods (irregular periods) was resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ENTYVIO; MESALAMINE; AMLODIPINE; OLMESARTAN

Current Illness:

ID: 1508493
Sex: M
Age:
State: NY

Vax Date: 04/11/2021
Onset Date: 04/19/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Left arm from injection site became very sore.; lower neck became very sore.; shoulder blade became very sore.; fore arm area became very sore.; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158), via an unspecified route of administration in the left arm on 11Apr2021 at 17:00 (at the age of 55-year-old), as a single dose for COVID-19 immunisation. Medical history included hypertension and asthma. Concomitant medications included metoprolol succinate (METOPROLOL), atorvastatin (MANUFACTURER UNKNOWN), lamotrigine (MANUFACTURER UNKNOWN) and fluticasone furoate; umeclidinium bromide; vilanterol trifenatate (TRELEGY) for an unknown indication from an unknown date. The patient did not have a history of past drug therapy. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Apr2021, the patient had experienced very sore left arm from injection site to lower neck to shoulder blade and down my arm to my fore arm area which started about 7 days after injection and was still feeling the same till the day of report. Therapeutic measures were taken as the result of adverse events, which included treatment with heating pad. The clinical outcome of the events very sore left arm from injection site to lower neck to shoulder blade and down my arm to my fore arm area was not resolved at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: ATORVASTATIN; LAMOTRIGINE; TRELEGY; METOPROLOL

Current Illness:

ID: 1508494
Sex: F
Age:
State: AR

Vax Date:
Onset Date: 04/23/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: right arm swollen; itchy; fever; bruised; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm right on 02Apr2021 at 10:00 (at the age of 42-year-old) and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the arm right on an unknown date, both as a single dose for COVID-19 immunisation. Medical history included stroke, blood pressure high and high cholesterol. Concomitant medications included too many unspecified drugs (as reported). The patient previously took Peroxide and adhesive. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 the patient experienced two spots covering the top right arm swollen, itchy, fever and bruised. They looked like a bullseye as reported. The clinical outcome of the events arm swollen, itchy, fever and bruised were not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508495
Sex: M
Age:
State: NY

Vax Date: 04/11/2021
Onset Date: 04/11/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tired; Slept most of the day; Strong muscle aches; Body aches; Restless all night; Low grade fever; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 11Apr2021 at 11:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. Concomitant medications included lisinopril 10mg (MANUFACTURER UNKNOWN), allium sativum extract (KYOLIC GARLIC), ascorbic acid, tocopheryl acetate, ubidecarenone, zinc oxide, cupric oxide, betacarotene, selenium, manganese sulfate (COQ10), cyanocobalamin (VITAMIN B12) and colecalciferol (VITAMIN D3), all taken for unknown indications from unknown dates. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 21Mar2021 at 11:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 18:00, the patient experienced body aches, was restless all night, slept little and had low grade fever overnight which continued to 12Apr2021. On 12Apr2021, the patient had slept most of the day, had strong muscle aches. On 13Apr2021, the patient felt tired. The clinical outcome of the events body aches, restless all night, slept little, low grade fever, slept most of the day, strong muscle aches and tired were resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: LISINOPRIL; KYOLIC GARLIC; Coq10; vitamin b12; VITAMIN D3

Current Illness:

ID: 1508496
Sex: F
Age:
State: IN

Vax Date: 04/15/2021
Onset Date: 04/17/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Developed a stye on right eye; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737), via an unspecified route of administration in the arm left on 15Apr2021(at the age of 41-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534), via an unspecified route of administration in the arm left on 25Mar2021(at the age of 41-year-old), as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested positive for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021, the patient developed a stye on right eye after receiving the second vaccine. The patient never had a stye before. The clinical outcome of the event stye on right eye was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508497
Sex: F
Age:
State: VA

Vax Date: 04/29/2021
Onset Date: 04/29/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tiny red dots appeared on my stomach after the vaccine; This is a spontaneous report from a contactable consumer, the patient. A 18-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 29Apr2021 at 09:30 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any medications within two weeks prior to the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Previously the patient was not on any drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Apr2021 at 12:15, after the vaccination, the patient experienced tiny red dots on stomach. The clinical outcome of the event tiny red dots on stomach was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508498
Sex: F
Age:
State: IN

Vax Date: 01/27/2021
Onset Date: 02/10/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Horrible genital herpes outbreak; This is a spontaneous report from a contactable nurse, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 27Jan2021(at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patient previously received PCN for unknown indication on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 10Feb2021, the patient experienced horrible genital herpes outbreak. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken for the treatment of reported events which included valacyclovir (VALTREX) and pain medications(unspecified). The clinical outcome of the event horrible genital herpes outbreak was unknown at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1508499
Sex: M
Age:
State: MI

Vax Date: 04/20/2021
Onset Date: 04/22/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Lymph node tenderness; Lymph node under right arm became enlarged; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 20Apr2021 at 14:00 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high. The patient had no known past drug history. Concomitant medications included lisinopril 10 mg (MANUFACTURER UNKNOWN) and omeprazole 20 mg (MANUFACTURER UNKNOWN) both from an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 30Mar2021 at 14:30 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 22Apr2021 at 03:00, the patient experienced lymph node enlarged and lymph node pain. Its reported that the patient's lymph node under right arm became enlarged. This happened a day and a half later than the shot. It was tender and uncomfortable and lasted for 6 days. The clinical outcome of the events of lymph node enlarged and lymph node tenderness were recovered on 28Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: LISINOPRIL; OMEPRAZOLE

Current Illness:

ID: 1508500
Sex: M
Age:
State: IL

Vax Date: 04/26/2021
Onset Date: 04/28/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Left under arm (lymph node) very sore; This is a spontaneous report from a contactable consumer, the patient. A 43-years-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 26Apr2021 at 12:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included fluvoxamine maleate (LUVOX), lamotrigine (MANUFACTURER UNKNOWN), simvastatin (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and proto from an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 12:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 28Apr2021, the patient experienced left underarm (lymph node) very sore. The clinical outcome of the event left underarm (lymph node) very sore was not recovered at the time of the report. No follow-up attempts are needed; information about the lot number cannot be obtained.

Other Meds: Luvox; LAMOTRIGINE; SIMVASTATIN; LISINOPRIL

Current Illness:

ID: 1508501
Sex: M
Age:
State: NC

Vax Date: 03/31/2021
Onset Date: 04/09/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Inflammation on the top of left elbow to the point that patient can barely use left arm. Inflammation in left shoulder and the injection site has become tender again. Now having some inflammation in knees and right elbow area; Injection site had become tender again; This is a spontaneous report from a contactable consumer, the patient. A 48-years-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534, Expiration date: 31Jul2021) via an unspecified route of administration in the left arm on 31Mar2021 at 09:45 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included postural orthostatic tachycardia syndrome. The patient had no past drugs. Concomitant medications included esomeprazole sodium (NEXIUM), vitamin B (MANUFACTURER UNKNOWN), vitamin D (MANUFACTURER UNKNOWN) and probiotic (MANUFACTURER UNKNOWN), all for unknown indications, on an unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, within 1 to 1.5 weeks after receiving the vaccine, the patient experienced inflammation on the top of left elbow to the point that the patient can barely use his left arm, now had inflammation in left shoulder and the injection site had become tender again. The patient also had some inflammation in knees and right elbow area. It was reported that the patient never had inflammation in joints; especially in the left arm/elbow joint until after he was vaccinated (2nd dose) and had no injuries or accidents, and prior to receiving the vaccine the patient did not have pain in these areas. Therapeutic measures were taken and included treatment with ice and ibuprofen (MANUFACTURER UNKNOWN) etc., with no relief. The clinical outcome of the events inflammation and injection site has become tender again was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: Nexium; Vitamin b; Vitamin d

Current Illness:

ID: 1508502
Sex: F
Age:
State: CA

Vax Date: 04/28/2021
Onset Date: 04/29/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Blistering at injection site; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration on 28Apr2021 at 14:30 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included occasional ibuprofen (MANUFACTURER UNKNOWN) and calcium supplement (MANUFACTURER UNKNOWN) both for an unknown indication on an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) on the arm left via an unspecified route of administration on 07Apr2021 at 15:30 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 10:00 the patient experienced blistering at injection site. The clinical outcome of the event blistering at injection site was unknown at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: IBUPROFEN

Current Illness:

ID: 1508503
Sex: F
Age:
State: FL

Vax Date: 04/28/2021
Onset Date: 04/28/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dizziness; Hot flashes; Cold flashes; So much sweating; Headache; Full body soreness; Vision started to get blurred; Felt weak when standing; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Apr2021 at 11:45 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history included depression. Concomitant medications included bupropion hydrochloride (WELLBUTRIN SR). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 12:45 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Apr2021 at 17:45, the patient experienced dizziness, hot, cold flashes, sweating, headache, full body soreness, vision started to get blurred at the dudes and felt weak when standing. It was reported that the patient had to take the day off school because she could not get out of bed. The patient received treatment with TYLENOL for the reported events. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event dizziness, hot, cold flashes, sweating, headache, full body soreness, vision started to get blurred and felt weak when standing were resolving at the time of report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: WELLBUTRIN SR

Current Illness:

ID: 1508504
Sex: F
Age:
State: AL

Vax Date: 03/12/2021
Onset Date: 03/12/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Cough; Shortness of breath (SOB); lethargy; Head ache; 8 hours after vaccine. high fever 101-102 x 2 days.; This is a spontaneous report from a contactable nurse. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EI.8982) via an unspecified route of administration in the right arm on 12Mar2021 at 12:00 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications was not reported. The patient previously took bromocriptine mesylate(PARLODEL) and erythromycin(MANUFACTURER UNKNOWN) ointment from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 12Mar2021 at 20:00, 8 hours after vaccination, the patient experienced high fever of 101-102 for 2 days, cough, head ache, shortness of breath (SOB), lethargy for 7 days. The patient underwent lab test which included body temperature on 12Mar2021 and resulted with a temperature of 101-102(unspecified unit). On 14Mar2021, the patient underwent SARS-CoV-2 test(nasal swab) and the result was negative. The clinical outcome of the event high fever, cough, head ache, shortness of breath (SOB), lethargy were recovered on unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508505
Sex: F
Age:
State: IN

Vax Date: 04/26/2021
Onset Date:
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever - 103 F; Urine Infection; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Apr2021 at 10:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 10:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in 2021, the patient experienced fever-103 F and urine infection. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of fever-103 F and urine infection and included treatment with unspecified antibiotics. The outcomes of the fever-103 F and urine infection were recovering. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1508506
Sex: M
Age:
State: CA

Vax Date: 04/02/2021
Onset Date: 04/06/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: episodes of hives(torso, arms and legs), severe hives for a few days. Subsequent weeks I have had occasional hive/red itchy bumps.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the arm left on 02Apr2021 at 12:30(at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included atrial fibrillation, blood pressure high, hay fever, and vitiligo. The patient did not take any concomitant medication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 12Mar2021 at 12:30 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021, the patient experienced episodes of hives (torso, arms and legs). The event started 3 or so days after vaccine, severe hives for a few days. Subsequent weeks he had occasional hive and red itchy bumps through previous day. Total 10-12 days' worth of episodes. It was reported that he had not had episode of hives in as long as he could remember, maybe 20+ years and never recurring. Therapeutic measures were taken as a result of reported event and included treatment with Zyrtec. The events resulted in doctor or other healthcare professional office/clinic visit, The clinical outcome of the events hives and red itchy bumps were not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508507
Sex: F
Age:
State: VA

Vax Date: 03/24/2021
Onset Date: 04/06/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pain in hands and at the base of thumbs; pain in right hamstring and calf muscles, then moved to left hamstring and calf muscles; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732), via an unspecified route of administration in the arm left on 24Mar2021 at 17:30 (at the age of 59-year-old), as a single dose for COVID-19 immunisation. Medical history included depression and obesity on unknown dates. Concomitant medications included citalopram (MANUFACTURER UNKNOWN), omeprazole (PROTONIX) and ascorbic acid, biotin, boron, calcium, calcium pantothenate, chlorine, chromium, cholecalciferol, copper, cyanocobalamin, folic acid, iodine, magnesium, manganese, molybdenum, nickel, nicotinamide, phosphorus, phytomenadione, potassium, pyridoxine hydrochloride, retinol, riboflavin, selenium, silicon dioxide, thiamine hydrochloride, tocopherol, vanadium, zinc (CENTRUM SILVER) from an unknown dates taken for an unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously took codeine (MANUFACTURER UNKNOWN) for an unknown indication on unknown dates. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021, the patient experienced pain in right hamstring and calf muscles, then moved to left hamstring and calf muscles (muscle pain) and also the patient experienced pain in hands and at the base of thumbs (pain in extremity). The adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events (pain in right hamstring and calf muscles, then moved to left hamstring and calf muscles and pain in hands and at the base of thumbs) and included treatment with X-rays, physical therapy (PT) and unspecified medications on unknown dates. The clinical outcome of the events pain in hands and at the base of thumbs and pain in right hamstring and calf muscles, then moved to left hamstring and calf muscles was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: CITALOPRAM; Protonix; Centrum silver

Current Illness:

ID: 1508508
Sex: F
Age:
State: WA

Vax Date: 04/29/2021
Onset Date: 04/29/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EK8736) via an unspecified route of administration in the right arm on 29Apr2021 at 07:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, allergy to eggs, dairy, peppers, pineapple, walnut. Concomitant medications included enalapril (MANUFACTURER UNKNOWN), hydrochlorothiazide (HCTZ) from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Apr2021 at 08:30 the patient experienced dizziness. The clinical outcome of the event dizziness was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: ENALAPRIL; HCTZ

Current Illness: Allergy to nuts (walnut allergy); Egg allergy (eggs allergy); Food allergy (peppers allergy); Fruit allergy (pineapple allergy); Milk allergy (dairy allergy)

ID: 1508509
Sex: F
Age:
State: WA

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen lymph nodes under both arms, around both sides of neck and in groin; Swollen lymph nodes under both arms, around both sides of neck and in groin; Swollen lymph nodes under both arms, around both sides of neck and in groin; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the arm left on 16Apr2021 at 13:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the arm left on 10Mar2021 at 13:30 as a single dose for COVID-19 immunisation. The patient previously received DTaP vaccine (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced rash and severe lymph node reaction (not specified). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 17Apr2021 at 09:00, the patient experienced swollen lymph nodes under both arms, around both sides of neck and in groin. The clinical outcome of the events swollen lymph nodes under both arms, around both sides of neck and in groin were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508510
Sex: F
Age:
State: KS

Vax Date: 04/28/2021
Onset Date: 04/28/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Feeling hot; Loud high pitched ringing in ears; Extreme pain in joints-caused severe pain from lumbar surgical site to return,; Vomiting; Extreme exhaustion; Fever; Headache; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the arm left on 28Apr2021 at 11:45 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis, multiple disabling back conditions with surgeries and rheumatoid arthritis. The patient received other medications within two weeks of vaccination. Past drug history includes sulfa and penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 14:00 the patient experienced vomiting, extreme exhaustion, felt hot, fever, extreme pain in joints-caused severe pain from lumbar surgical site to return, headache and loud high-pitched ringing in ears. The clinical outcome of the events vomiting, extreme exhaustion, felt hot, fever, extreme pain in joints-caused severe pain from lumbar surgical site to return, headache, loud high pitched ringing in ears were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508511
Sex: F
Age:
State: AL

Vax Date: 04/28/2021
Onset Date: 04/29/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Whole body aching; Headache; Blood pressure elevated; This is a spontaneous report from a contactable nurse, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 28Apr2021(at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS) from an unknown date. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 07Apr2021(at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient previously took peanut on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 29Apr2021 at 00:00, the patient experienced whole body aching, headache and blood pressure elevated. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events whole body aching, headache and blood pressure elevated was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1508512
Sex: F
Age:
State: TX

Vax Date: 04/10/2021
Onset Date: 04/29/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Menstruated one week early; Menstruated one week early with increased pre-menstruated symptoms; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 10Apr2021 at 12:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety. Concomitant medications included sertraline hydrochloride (ZOLOFT) for unknown indication on an unknown date. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 20Mar2021 at 15:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 00:00, the patient experienced menstruated one week early with increased pre-menstruated symptoms. Therapeutic measures taken were not reported. The clinical outcome of the events menstruated one week early with increased pre-menstruated symptoms was unknown at the time of report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ZOLOFT

Current Illness:

ID: 1508513
Sex: F
Age:
State: CA

Vax Date: 04/26/2021
Onset Date: 04/28/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Metallic taste in the mouth, that has so far lasted two days.; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 26Apr2021 at 12:00 as a single dose for COVID-19 immunisation. Medical history was not reported. The patient previously received treatment with hydrocodone bitartarate, paracetamol (VICODIN) for unknown indication on an unknown date and experienced drug allergy. The patient did not receive any concomitant medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on an unknown date in Apr2021 at 12:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021, the patient experienced metallic taste in the mouth, that has so far lasted two days. The clinical outcome of the event metallic taste in the mouth, that has so far lasted two days was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508514
Sex: F
Age:
State: VT

Vax Date: 04/24/2021
Onset Date: 04/25/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: loose cough; chills; slight increase in temp (no higher than 100.8) for 24 hours; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the arm left on 24Apr2021 at 11:30 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included environmental allergy, sinus infection (Chronic sinus infections) and upper respiratory disorder (chronic upper respiratory issues). Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), acetylsalicylic acid, caffeine (BAYER BACK & BODY PAIN) and acetylsalicylic acid (ASPRIN) from unknown dates taken for unknown indications. The patient previously took erythromycin (MANUFACTURER UNKNOWN) for unknown indication on unknown date. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the arm left on 03Apr2021 at 13:45 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 25Apr2021 at 07:30, the patient experienced incredible chills, slight increase in temp (no higher than 100.8) for 24 hours, and a cough. It had been 5 days and the patient still had a loose cough that the patient was concerned about and the patient would like to talk to someone before making an appointment with her physician to discuss a course of treatment and need to know about medications that her physician normally prescribes for upper respiratory problems vs. vaccine ingredients. The clinical outcome of the event loose cough was not recovered at the time of this report. The clinical outcome of the event slight increase in temp (no higher than 100.8) for 24 hours and chills was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LISINOPRIL; BAYER BACK & BODY PAIN; ASPRIN

Current Illness:

ID: 1508515
Sex: M
Age:
State: MD

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Apathetic; Fatigued; Tired; Exhausted; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164), via an unspecified route of administration in the left arm on 19Apr2021 at 11:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other medication within two weeks of the COVID-19 vaccination. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) and CECLOR from unknown dates for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 29Mar2021 at 11:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021 at 13:00, the patient felt tired, fatigued, exhausted and apathetic. On 28Apr2021, the patient underwent a nasal swab test (SARS-CoV-2 test) and tested negative. The clinical outcome of the events felt tired, fatigued, exhausted and apathetic was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508516
Sex: M
Age:
State: FL

Vax Date: 04/27/2021
Onset Date: 04/28/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: chills; body aches; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 27Apr2021 at 13:30 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 06Apr2021 at 13:15 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 01:00, within 12 hours of vaccination, the patient experienced chills and body aches. The clinical outcome of the events chills and body aches was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508517
Sex: F
Age:
State: MA

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Loud tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 21Apr2021 at 11:00 (at the age of 60-years-old), as a single dose for COVID-19 immunisation. Medical history included unidentified autoimmunity issues. The patient did not receive any other medication within two weeks of vaccination. The patient previously took gluten, tree nuts and some antibiotics. The patient previously received varicella zoster vaccine rge (CHO) (SHINGRIX) on an unknown date for immunisation. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 31Mar2021 at 11:00 (at the age of 60-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 22Apr2021, the patient experienced loud tinnitus. The clinical outcome of the event loud tinnitus was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508518
Sex: F
Age:
State: IL

Vax Date: 04/23/2021
Onset Date: 04/27/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchy rash on cheek bones (small bumps), later spread to chest, under eyebrows and behind ears; This is a spontaneous report from a contactable consumer. A 47-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 23Apr2021 at 14:30 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol and seasonal allergies. The patient has taken unspecified concomitant medications. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 01Apr2021 at 14:30 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Apr2021, the patient experienced itchy rash. It was reported that the patient experienced itchy rash on cheek bones (small bumps), later spread to chest, under eyebrows and behind ears. The patient has taken benadryl (MANUFACTURER UNKNOWN) as a treatment for the adverse event. It was unknown whether the adverse event resulted in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event itchy rash was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1508519
Sex: F
Age:
State: FL

Vax Date: 04/05/2021
Onset Date: 04/16/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: right upper arm is not functioning properly and cannot lift the right arm above the waist.; tingling in wrist and hand as well; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737), via an unspecified route of administration in the right arm on 05Apr2021 at 16:00 (at the age of 63-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208), via an unspecified route of administration in the right arm on 15Mar2021 at 16:00 (at the age of 63-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not tested positive for COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Apr2021 at 14:00, the patient experienced right upper arm was not functioning properly, cannot lift right arm above the waist and had some tingling in the wrist and hand. The clinical outcome of the events right upper arm was not functioning properly, cannot lift right arm above the waist and had some tingling in the wrist and hand was not resolved. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508520
Sex: F
Age:
State: CO

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Little red acne-like bumps that are painful to touch; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 12:00 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient's past drugs were unknown. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 00:00, the patient experienced little red acne-like bumps that are painful to touch which lasted for 2 weeks. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event red acne-like bumps that are painful was resolved on an unknown date in Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm